Table 2.
Differentially expressed genes in regulation of actin cytoskeleton and TGF-β signaling between SLE patients and normal controls.
| Upregulated genes in actin cytoskeleton pathway | Fold | P value |
|---|---|---|
| ACTN4 | 2.30 | ≤1.0E − 6 |
| ACTB | 2.41 | ≤1.0E − 6 |
| VAV1 | 4.08 | ≤1.0E − 6 |
| MATK | 2.85 | ≤1.0E − 6 |
| ITGB5 | 8.46 | ≤1.0E − 6 |
| ITGB4 | 2.43 | ≤1.0E − 6 |
|
| ||
| Downregulated genes in actin cytoskeleton pathway | ||
|
| ||
| KRAS | 5.62 | ≤1.0E − 6 |
| ARPC3 | 2.17 | ≤1.0E − 6 |
| ARPC4 | 2.10 | ≤1.0E − 6 |
| ARPC5 | 2.53 | ≤1.0E − 6 |
| NRAS | 2.01 | ≤1.0E − 6 |
| GNG12 | 2.17 | ≤1.0E − 6 |
| NCKAP1 | 3.16 | ≤1.0E − 6 |
| ITGA1 | 3.63 | ≤1.0E − 6 |
| CRKL | 2.71 | ≤1.0E − 6 |
| ITGB5 | 2.58 | ≤1.0E − 6 |
| PPP1CC | 3.36 | ≤1.0E − 6 |
| CFL2 | 2.06 | ≤1.0E − 6 |
| ROCK2 | 2.38 | ≤1.0E − 6 |
| PDGFRA | 2.77 | ≤1.0E − 6 |
| F2R | 2.57 | ≤1.0E − 6 |
| RDX | 2.23 | ≤1.0E − 6 |
| PPP1R12A | 2.99 | ≤1.0E − 6 |
| ARHGEF6 | 2.31 | ≤1.0E − 6 |
| ITGAV | 7.84 | ≤1.0E − 6 |
| CRK | 2.71 | ≤1.0E − 6 |
|
| ||
| Upregulated genes TGF-β signaling | ||
|
| ||
| BMP5 | 4.23 | ≤1.0E − 6 |
|
| ||
| Downregulated genes TGF-β signaling | ||
|
| ||
| SMAD1 | 2.08 | ≤1.0E − 6 |
| SMAD5 | 2.60 | ≤1.0E − 6 |
| SMURF2 | 2.66 | ≤1.0E − 6 |
| ID1 | 3.81 | ≤1.0E − 6 |
| BMPR1A | 3.03 | ≤1.0E − 6 |
| TGFBR1 | 4.50 | ≤1.0E − 6 |
| TGFBR2 | 2.01 | ≤1.0E − 6 |
| ACVR1 | 3.12 | ≤1.0E − 6 |
| CREBBP | 2.06 | ≤1.0E − 6 |
| ROCK2 | 2.38 | ≤1.0E − 6 |
| RPS6KB1 | 2.64 | ≤1.0E − 6 |
| CDKN2B | 2.03 | ≤1.0E − 6 |
| THBS1 | 3.14 | ≤1.0E − 6 |
| THBS3 | 2.11 | ≤1.0E − 6 |
| THBS2 | 3.05 | ≤1.0E − 6 |
| LTBP1 | 2.27 | ≤1.0E − 6 |
| COMP | 4.89 | ≤1.0E − 6 |
| FST | 2.23 | ≤1.0E − 6 |